Altimmune, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2011 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Altimmune, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2011 to Q1 2024.
- Altimmune, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$16.4M, a 15.7% increase year-over-year.
- Altimmune, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$75.8M, a 21.1% decline from 2022.
- Altimmune, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$62.6M, a 20% increase from 2021.
- Altimmune, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$78.2M, a 128% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)